371 related articles for article (PubMed ID: 19931652)
1. Enhanced fibrinolysis by proteolysed coagulation factor Xa.
Talbot K; Meixner SC; Pryzdial EL
Biochim Biophys Acta; 2010 Apr; 1804(4):723-30. PubMed ID: 19931652
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic modulation of factor Xa-antithrombin complex enhances fibrinolysis in plasma.
Talbot K; Meixner SC; Pryzdial EL
Biochim Biophys Acta; 2013 Jun; 1834(6):989-95. PubMed ID: 23416531
[TBL] [Abstract][Full Text] [Related]
3. Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity.
Carter RLR; Talbot K; Hur WS; Meixner SC; Van Der Gugten JG; Holmes DT; Côté HCF; Kastrup CJ; Smith TW; Lee AYY; Pryzdial ELG
J Thromb Haemost; 2018 Nov; 16(11):2276-2288. PubMed ID: 30176116
[TBL] [Abstract][Full Text] [Related]
4. Autoproteolysis or plasmin-mediated cleavage of factor Xaalpha exposes a plasminogen binding site and inhibits coagulation.
Pryzdial EL; Kessler GE
J Biol Chem; 1996 Jul; 271(28):16614-20. PubMed ID: 8663221
[TBL] [Abstract][Full Text] [Related]
5. Thrombolysis by chemically modified coagulation factor Xa.
Pryzdial EL; Meixner SC; Talbot K; Eltringham-Smith LJ; Baylis JR; Lee FM; Kastrup CJ; Sheffield WP
J Thromb Haemost; 2016 Sep; 14(9):1844-54. PubMed ID: 27359348
[TBL] [Abstract][Full Text] [Related]
6. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
[TBL] [Abstract][Full Text] [Related]
7. Herpesviruses enhance fibrin clot lysis.
Gershom ES; Vanden Hoek AL; Meixner SC; Sutherland MR; Pryzdial EL
Thromb Haemost; 2012 Apr; 107(4):760-8. PubMed ID: 22318336
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of blood coagulation factor Xaalpha autoproteolytic conversion to factor Xabeta. Effect on inhibition by antithrombin, prothrombinase assembly, and enzyme activity.
Pryzdial EL; Kessler GE
J Biol Chem; 1996 Jul; 271(28):16621-6. PubMed ID: 8663222
[TBL] [Abstract][Full Text] [Related]
9. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
10. The role of activated coagulation factor XII in overall clot stability and fibrinolysis.
Konings J; Hoving LR; Ariëns RS; Hethershaw EL; Ninivaggi M; Hardy LJ; de Laat B; Ten Cate H; Philippou H; Govers-Riemslag JW
Thromb Res; 2015 Aug; 136(2):474-80. PubMed ID: 26153047
[TBL] [Abstract][Full Text] [Related]
11. The effect of plasmin-mediated degradation on fibrinolysis and tissue plasminogen activator diffusion.
Bannish BE; Paynter B; Risman RA; Shroff M; Tutwiler V
Biophys J; 2024 Mar; 123(5):610-621. PubMed ID: 38356261
[TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
Wu JH; Diamond SL
J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
[TBL] [Abstract][Full Text] [Related]
14. The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
Suenson E; Bjerrum P; Holm A; Lind B; Meldal M; Selmer J; Petersen LC
J Biol Chem; 1990 Dec; 265(36):22228-37. PubMed ID: 2148318
[TBL] [Abstract][Full Text] [Related]
15. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of initiation of fibrinolysis by fibrin.
Medved L; Nieuwenhuizen W
Thromb Haemost; 2003 Mar; 89(3):409-19. PubMed ID: 12624622
[TBL] [Abstract][Full Text] [Related]
17. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.
Jones AJ; Meunier AM
Thromb Haemost; 1990 Nov; 64(3):455-63. PubMed ID: 2128976
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of tPA-dependent provisional extracellular fibrin matrix degradation by human recombinant soluble melanotransferrin.
Bertrand Y; Demeule M; Rivard GE; Béliveau R
Biochim Biophys Acta; 2006 Oct; 1763(10):1024-30. PubMed ID: 16979249
[TBL] [Abstract][Full Text] [Related]
19. Plasmin converts factor X from coagulation zymogen to fibrinolysis cofactor.
Pryzdial EL; Lavigne N; Dupuis N; Kessler GE
J Biol Chem; 1999 Mar; 274(13):8500-5. PubMed ID: 10085082
[TBL] [Abstract][Full Text] [Related]
20. Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.
Bauer R; Hansen SL; Jones G; Suenson E; Thorsen S; Ogendal L
Eur Biophys J; 1994; 23(4):239-52. PubMed ID: 7805626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
